Title: A Case Report of Infantile Hemangioma
Authors: Dr P. Pari, Dr Nalini MD, DM (Neonatalogy), Dr N.S. Raghupathy, D.Ch., M.D., Ph.D.
DOI: https://dx.doi.org/10.18535/jmscr/v7i10.04
Abstract
Infantile Hemangioma are proliferative, benign vascular tumours of vascular endothelium that may be present at birth or present in first two weeks of life, predictably enlarge and then involute spontaneously. We report an infant with Infantile Hemangioma in multiple sites and moderate Ostium Secundum type Atrial Septal Defect with Left to Right shunt. The baby is started on Tablet Propranolol. Clinically we can diagnose Infantile Hemangioma. But need to rule out systemic involvement like PHACES Syndrome and Kasabach Merritt phenomenon.
Keywords: Infantile Hemangioma, Propranolol, Vascular Tumours.
References
- Nelson Textbook of Pediatrics. First South Asia Edition. Vol.3, Page No. 3124—3128.
- LM Burkmiller, GT Richter, JY Suen. Diagnosis and Management of Hemangiomas and Vascular Malformations of the Head and Neck. Oral Diseases (2010)16.405-418.
- Zia Khan, Elisa Boscolo, Arnaud Picard, et. al. Multipotential stem cells recapitulate human Infantile Hemangioma in immunodeficient mice. The Journal of Clinical Investigation. 118(7),2592-2599, 2008.
- Anil Abraham, Anupav Mary Job, Gillian Roga. Indian Journal of Dermatology. 2016; Vol.61; Issue:2, Page No. 181-186.
- Karina L Vivar, Antony J Mancini. Indian Journal of Pediatric Dermatology - Infantile Hemangiomas: An Update on Pathogenesis, Associations and Management. 2018; Vol.19; Issue- 4. Page No. 293-303.
- Veronique Sans, Eric Dumas da la Roque, et. al. Propranolol for severe Infantile Hemangiomas: follow-up report. American Academy of Pediatrics 124(3). e423-e431, 2009.
- Christine Leaute - Labreze, Eric Dumas de la Roque, et. al. New England Journal of Medicine. Propranolol for severe Hemangiomas of Infancy. 358(24),2649-2651,2008.
- Jessica Stiles, Clarissa Amaya, Robert Pham, et. al. Spandidos Publications. Propranolol Treatment of Infantile Hemangioma Endothelial cells: A molecular analysis. Experimental and therapeutic medicine. 4(4), 594-604, 2012.